David C. Marek

Insider Reports History

Location
New York, NY
Signature
/s/ Matthew Lang, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David C. Marek:

Company Role Class Num Shares Value Price $ Report Date Ownership
Myovant Sciences Ltd. Principal Executive Officer, Director Common Shares 0 $27.00 10 Mar 2023 Direct
Myovant Sciences Ltd. Principal Executive Officer, Director Performance Stock Unit 0 10 Mar 2023 Direct
Myovant Sciences Ltd. Principal Executive Officer, Director Stock Options (Right to Buy) 0 10 Mar 2023 Direct

Insider Reports Filed by David C. Marek

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123017720-marek-david-c-2023-03-10 Myovant Sciences Ltd. 10 Mar 2023 6 $0 4 Principal Executive Officer, Director 10 Mar 2023, 08:30
/report/000120919123004282-marek-david-c-2023-01-18 Myovant Sciences Ltd. 18 Jan 2023 1 -$216,115 4 Principal Executive Officer, Director 20 Jan 2023, 15:34
/report/000120919122054196-marek-david-c-2022-10-18 Myovant Sciences Ltd. 18 Oct 2022 1 -$281,131 4 Principal Executive Officer, Director 20 Oct 2022, 16:53
/report/000120919122042688-marek-david-c-2022-07-18 Myovant Sciences Ltd. 18 Jul 2022 1 -$143,681 4 Principal Executive Officer, Director 20 Jul 2022, 16:36
/report/000120919122025170-marek-david-c-2022-04-19 Myovant Sciences Ltd. 19 Apr 2022 1 -$257,007 4 Principal Executive Officer, Director 21 Apr 2022, 16:25
/report/000120919122024784-marek-david-c-2022-04-15 Myovant Sciences Ltd. 15 Apr 2022 2 $0 4 Principal Executive Officer, Director 19 Apr 2022, 16:46
/report/000120919122004396-marek-david-c-2022-01-19 Myovant Sciences Ltd. 19 Jan 2022 1 -$291,868 4 Principal Executive Officer, Director 21 Jan 2022, 15:08